Advertisement
Advertisement
Trajenta

Trajenta Dosage/Direction for Use

linagliptin

Manufacturer:

Boehringer Ingelheim

Distributor:

DKSH
Full Prescribing Info
Dosage/Direction for Use
Posology: Adults: The recommended dose is 5 mg once daily. TRAJENTA can be taken with or without a meal at any time of the day.
Special populations: Renal impairment: No dose adjustment is required for patients with renal impairment.
Hepatic Impairment: No dose adjustment is required for patients with hepatic impairment.
Elderly: No dose adjustment is necessary. Experience in patients older than >75 years of age is limited.
Paediatric population: A clinical trial did not establish efficacy in paediatric patients 10 to 17 years of age (see Adverse Reactions, Pharmacology: Pharmacodynamics & Pharmacokinetics under Actions). Therefore, treatment of children and adolescents with TRAJENTA is not recommended.
TRAJENTA has not been studied in paediatric patients under 10 years of age.
Method of administration: Missed dose: If a dose is missed, it should be taken as soon as the patient remembers. A double dose should not be taken at the same day.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement